Stockreport

FDA Approves Genentech's TNKase® in Acute Ischemic Stroke in Adults [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF – Single five-second intravenous bolus provides faster and simpler administration than the approved standard-of-care – – Genentech has developed the only two FDA-appr [Read more]